1From Harvard Medical School and Psychopharmacology Program & International Consortium for Bipolar Disorder Research, McLean Hospital, Belmont, MA (Drs Baldessarini, Vieta, and Tohen); Bipolar Disorder Program, Department of Psychiatry, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain (Dr. Vieta); Department of Psychiatry, University Hospitals–Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH (Dr. Calabrese); Department of Psychiatry, University of Texas Health Science Center at San Antonio (Drs. Tohen and Bowden).
Supported, in part, by a grant from the Bruce J. Anderson Foundation and by the McLean Private Donors Research Fund (to RJB); and by the Spanish Ministry of Science and Innovation (PR 2007–0358), Centro de Investigacion Biomedica en Red en Salud Mental (to EV).
*Correspondence: Ross Baldessarini, MD, Mailman Research Center 308, McLean Hospital, 115 Mill St., Belmont, MA 02478. E-mail:[email protected]
Original manuscript received April 19, 2009; revised manuscript received August 31, 2009, accepted for publication September 23, 2009.
